Huie Jing1, Qian Zhang1, Yu Zhang1, Brenna J Hill2, Christopher G Dove1, Erwin W Gelfand3, T Prescott Atkinson4, Gulbu Uzel5, Helen F Matthews6, Peter J Mustillo7, David B Lewis8, Fotini D Kavadas9, I Celine Hanson10, Ashish R Kumar11, Raif S Geha12, Daniel C Douek2, Steven M Holland5, Alexandra F Freeman5, Helen C Su13. 1. Laboratory of Host Defenses, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md. 2. Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md. 3. Division of Allergy and Immunology, Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, Colo. 4. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Ala. 5. Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md. 6. Laboratory of Immunology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md. 7. Division of Infectious Diseases and Immunology, Nationwide Children's Hospital, Columbus, Ohio. 8. Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Stanford University, Stanford, Calif. 9. Section of Clinical Immunology and Allergy, Department of Pediatrics, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada. 10. Section of Allergy and Immunology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Tex. 11. Cancer and Blood Diseases Institute, Division of Bone Marrow Transplantation and Immune Deficiency and Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio. 12. Division of Immunology and Department of Pediatrics, Children's Hospital and Harvard Medical School, Boston, Mass. 13. Laboratory of Host Defenses, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Md. Electronic address: hsu@niaid.nih.gov.
Abstract
BACKGROUND: Autosomal recessive loss-of-function mutations in dedicator of cytokinesis 8 (DOCK8) cause a combined immunodeficiency characterized by atopy, recurrent infections, and cancer susceptibility. A genotype-phenotype explanation for the variable disease expression is lacking. OBJECTIVE: We investigated whether reversions contributed to the variable disease expression. METHODS: Patients followed at the National Institutes of Health's Clinical Center were studied. We performed detailed genetic analyses and intracellular flow cytometry to detect DOCK8 protein expression within lymphocyte subsets. RESULTS: We identified 17 of 34 DOCK8-deficient patients who had germline mutations with variable degrees of reversion caused by somatic repair. Somatic repair of the DOCK8 mutations resulted from second-site mutation, original-site mutation, gene conversion, and intragenic crossover. Higher degrees of reversion were associated with recombination-mediated repair. DOCK8 expression was restored primarily within antigen-experienced T cells or natural killer cells but less so in naive T or B cells. Several patients exhibited multiple different repair events. Patients who had reversions were older and had less severe allergic disease, although infection susceptibility persisted. No patients were cured without hematopoietic cell transplantation. CONCLUSIONS: In patients with DOCK8 deficiency, only certain combinations of germline mutations supported secondary somatic repair. Those patients had an ameliorated disease course with longer survival but still had fatal complications or required hematopoietic cell transplantation. These observations support the concept that some DOCK8-immunodeficient patients have mutable mosaic genomes that can modulate disease phenotype over time. Published by Mosby, Inc.
BACKGROUND: Autosomal recessive loss-of-function mutations in dedicator of cytokinesis 8 (DOCK8) cause a combined immunodeficiency characterized by atopy, recurrent infections, and cancer susceptibility. A genotype-phenotype explanation for the variable disease expression is lacking. OBJECTIVE: We investigated whether reversions contributed to the variable disease expression. METHODS:Patients followed at the National Institutes of Health's Clinical Center were studied. We performed detailed genetic analyses and intracellular flow cytometry to detect DOCK8 protein expression within lymphocyte subsets. RESULTS: We identified 17 of 34 DOCK8-deficient patients who had germline mutations with variable degrees of reversion caused by somatic repair. Somatic repair of the DOCK8 mutations resulted from second-site mutation, original-site mutation, gene conversion, and intragenic crossover. Higher degrees of reversion were associated with recombination-mediated repair. DOCK8 expression was restored primarily within antigen-experienced T cells or natural killer cells but less so in naive T or B cells. Several patients exhibited multiple different repair events. Patients who had reversions were older and had less severe allergic disease, although infection susceptibility persisted. No patients were cured without hematopoietic cell transplantation. CONCLUSIONS: In patients with DOCK8 deficiency, only certain combinations of germline mutations supported secondary somatic repair. Those patients had an ameliorated disease course with longer survival but still had fatal complications or required hematopoietic cell transplantation. These observations support the concept that some DOCK8-immunodeficientpatients have mutable mosaic genomes that can modulate disease phenotype over time. Published by Mosby, Inc.
Entities:
Keywords:
Dedicator of cytokinesis 8; T cell; allergy; gene conversion; immunodeficiency; intragenic single crossover; natural killer cell; recombination; reversion; somatic repair
Authors: Derek C Macallan; Becca Asquith; Andrew J Irvine; Diana L Wallace; Andrew Worth; Hala Ghattas; Yan Zhang; George E Griffin; David F Tough; Peter C Beverley Journal: Eur J Immunol Date: 2003-08 Impact factor: 5.532
Authors: T C Bittner; U Pannicke; E D Renner; G Notheis; F Hoffmann; B H Belohradsky; U Wintergerst; M Hauser; B Klein; K Schwarz; I Schmid; M H Albert Journal: Klin Padiatr Date: 2010-11-05 Impact factor: 1.349
Authors: Derek C Macallan; Diana L Wallace; Yan Zhang; Hala Ghattas; Becca Asquith; Catherine de Lara; Andrew Worth; George Panayiotakopoulos; George E Griffin; David F Tough; Peter C L Beverley Journal: Blood Date: 2005-01-11 Impact factor: 22.113
Authors: Karin R Engelhardt; Sean McGhee; Sabine Winkler; Atfa Sassi; Cristina Woellner; Gabriela Lopez-Herrera; Andrew Chen; Hong Sook Kim; Maria Garcia Lloret; Ilka Schulze; Stephan Ehl; Jens Thiel; Dietmar Pfeifer; Hendrik Veelken; Tim Niehues; Kathrin Siepermann; Sebastian Weinspach; Ismail Reisli; Sevgi Keles; Ferah Genel; Necil Kutukculer; Necil Kutuculer; Yildiz Camcioğlu; Ayper Somer; Elif Karakoc-Aydiner; Isil Barlan; Andrew Gennery; Ayse Metin; Aydan Degerliyurt; Maria C Pietrogrande; Mehdi Yeganeh; Zeina Baz; Salem Al-Tamemi; Christoph Klein; Jennifer M Puck; Steven M Holland; Edward R B McCabe; Bodo Grimbacher; Talal A Chatila Journal: J Allergy Clin Immunol Date: 2009-12 Impact factor: 10.793
Authors: Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su Journal: N Engl J Med Date: 2009-09-23 Impact factor: 91.245
Authors: Greg Crawford; Anselm Enders; Uzi Gileadi; Sanda Stankovic; Qian Zhang; Teresa Lambe; Tanya L Crockford; Helen E Lockstone; Alexandra Freeman; Peter D Arkwright; Joanne M Smart; Cindy S Ma; Stuart G Tangye; Christopher C Goodnow; Vincenzo Cerundolo; Dale I Godfrey; Helen C Su; Katrina L Randall; Richard J Cornall Journal: Blood Date: 2013-08-08 Impact factor: 22.113
Authors: Yan Zhang; Diana L Wallace; Catherine M de Lara; Hala Ghattas; Becca Asquith; Andrew Worth; George E Griffin; Graham P Taylor; David F Tough; Peter C L Beverley; Derek C Macallan Journal: Immunology Date: 2007-03-07 Impact factor: 7.397
Authors: Katrina L Randall; Teresa Lambe; Andy L Johnson; Andy Johnson; Bebhinn Treanor; Edyta Kucharska; Heather Domaschenz; Belinda Whittle; Lina E Tze; Anselm Enders; Tanya L Crockford; Tiphaine Bouriez-Jones; Duncan Alston; Jason G Cyster; Michael J Lenardo; Fabienne Mackay; Elissa K Deenick; Stuart G Tangye; Tyani D Chan; Tahra Camidge; Robert Brink; Carola G Vinuesa; Facundo D Batista; Richard J Cornall; Christopher C Goodnow Journal: Nat Immunol Date: 2009-11-08 Impact factor: 25.606
Authors: Karin R Engelhardt; Michael E Gertz; Sevgi Keles; Alejandro A Schäffer; Elena C Sigmund; Cristina Glocker; Shiva Saghafi; Zahra Pourpak; Ruben Ceja; Atfa Sassi; Laura E Graham; Michel J Massaad; Fethi Mellouli; Imen Ben-Mustapha; Monia Khemiri; Sara Sebnem Kilic; Amos Etzioni; Alexandra F Freeman; Jens Thiel; Ilka Schulze; Waleed Al-Herz; Ayse Metin; Özden Sanal; Ilhan Tezcan; Mehdi Yeganeh; Tim Niehues; Gregor Dueckers; Sebastian Weinspach; Turkan Patiroglu; Ekrem Unal; Majed Dasouki; Mustafa Yilmaz; Ferah Genel; Caner Aytekin; Necil Kutukculer; Ayper Somer; Mehmet Kilic; Ismail Reisli; Yildiz Camcioglu; Andrew R Gennery; Andrew J Cant; Alison Jones; Bobby H Gaspar; Peter D Arkwright; Maria C Pietrogrande; Zeina Baz; Salem Al-Tamemi; Vassilios Lougaris; Gerard Lefranc; Andre Megarbane; Jeannette Boutros; Nermeen Galal; Mohamed Bejaoui; Mohamed-Ridha Barbouche; Raif S Geha; Talal A Chatila; Bodo Grimbacher Journal: J Allergy Clin Immunol Date: 2015-02-25 Impact factor: 10.793